Eduardo Pisani became director general of the IFPMA in January 2010. An industry leader with over two decades of international pharmaceutical experience in companies like Bristol-Myers Squibb, Baxter, SmithKline Beecham, Immuno, he has seen health policy and patient access discussions evolve from a close vantage point, and is convinced that platforms for constructive policy discussion are essential to effective policymaking.